Impact Factor
3.38
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.78
633 total citations
h5-index
31
h5 depth signal
Cited share
67.5%
164 of 243
Total citations
633
Citation footprint
Metric signal
2.80
External metric anchor
Self-citation
6.8%
43 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
861
United Kingdom
212
Japan
204
Germany
119
Switzerland
110
Citing Fields of Research
Medical Ethics
1,027
Pharmacology & Toxicology
366
Statistical Methods
318
Patient Care
257
Healthcare Policy
233
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,881
Articles tracked across the journal lifetime
Indexed publication set
243
164 cited publications
Last 12 months
175
14.6 publications/month
Open access share
36.0%
63 OA publications in the last year
Leading citing country
United States
861 citing publications
Leading citing field
Medical Ethics
1,027 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v52n1, Jan. 2018-
v52n1, Jan. 2018- ; Selected citations only before this date
Research Focus & Classification
Indexed Subjects
Medical Ethics
Issuing & Sponsoring Bodies
issuing body
Drug Information Association
Broad Categories
Medicine
Therapeutics
Medical Ethics
MeSH Descriptors
Pharmaceutical Preparations
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
02
DOI 10.1007/s43441-026-01058-z
Open DOI
Protecting Trial Integrity Through Monitoring and Analysis of Medication Adherence
03
DOI 10.1007/s43441-026-01050-7
Open DOI
A Causal Inference Guided Analysis of Lung Transplant Outcomes Using Real-world Evidence from the SRTR Database
04
DOI 10.1007/s43441-026-01060-5
Open DOI
When Randomization Assigns a Starting Strategy: An Estimand-Led Framework for Frozen Embryo Transfer Trials
05
06
07
08
DOI 10.1007/s43441-026-01059-y
Open DOI
Implementation of the EU Clinical Trials Regulation and CTIS in Europe: a Comparative Regulatory Analysis (2013–2024)
09
10
DOI 10.1007/s43441-026-01046-3
Open DOI
Analysis of IMPD Deficiencies in the Clinical Trial Approval Process
The Investigational Medicinal Product Dossier (IMPD) represents a foundational component of the pharmaceutical and analytical quality documentation required for the approval of clinical trials. Situated within the broader structure of th...
Bibliographical & Catalog Notes
Also issued online.